Valued Retirements »

Edwards Lifesciences shares owned by Valued Retirements

Quarter-by-quarter ownership of Edwards Lifesciences (EW) shares owned by Valued Retirements from 13F filings

Historical chart of Valued Retirements investment in Edwards Lifesciences

Jan 2024Mar 2024May 2024Jul 2024Sep 2024Nov 2024Jan 2025220k240k25002600270028002900
Value ($)Share countHistorical EW position of Valued Retirements Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Edwards Lifesciences held by Valued Retirements consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edwards Lifesciences by Valued Retirements

Quarter filed Position value Share count Share price at filing
2024-12-31 $214k 2.9k 74.03
2024-06-30 $233k 2.5k 92.37
2024-03-31 $255k 2.7k 95.56
2023-12-31 $204k 2.7k 76.25

More positions owned by Valued Retirements

Invesco Qqq Tr Unit Ser 1 (QQQ)
Dimensional Etf Trust Internatnal Val (DFIV)
Exxon Mobil Corporation (XOM)
Invesco Exch Traded Fd Tr Ii S&p Smallcap 600 (RWJ)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Fidelity Covington Trust High Divid Etf (FDVV)
Cambria Etf Tr Shshld Yield Etf (SYLD)
Invesco Exch Trd Slf Idx Rusl 1000 Dynm (OMFL)
Ishares Em Mkt Sm-cp Etf (EEMS)
Microsoft Corporation (MSFT)
Ishares Gold Tr Ishares New (IAU)
Ishares Tr Rus Tp200 Gr Etf (IWY)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Invesco Exchange Traded Fd T S&p Mdcp Momntum (XMMO)

View all positions for Valued Retirements

Top funds holding Edwards Lifesciences

Vanguard Group
BlackRock
Wellington Management Company
State Street Corporation
Bank of New York Mellon
Jpmorgan Chase & Co
Geode Capital Management
Citadel Advisors
Fisher Investments
Norges Bank Investment Management
Brown Advisory Holdings Incorporated
Jennison Associates
Investec Asset Management
Morgan Stanley
Deutsche Bank Aktiengesellschaft

View all funds holding Edwards Lifesciences